ATP8A2 and metabolic syndrome: We also showed that the IDF- and ATP III-defined prevalence of MetS was slightly higher in women (23.3% and 16.6%) than in men (15.8% and 7.9%), respectively, and women demonstrated stronger associations between MetS occurrence and hypomagnesemia, even after adjusting for age and BMI.